Asia Pacific Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country
Market Introduction
Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period. With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections. In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific patient controlled injectors market is expected to reach US$ 1,637.74 million by 2027 from US$ 621.47 million in 2019. The market is anticipated to grow at a CAGR of 12.9% during 2019–2027. The increasing chronic diseases prevalence, and conventional drug delivery system limitations are the major factors expected to boost the growth of the patient controlled injectors market in Asia Pacific. However, the market is likely to get impacted by the risk factor such as lack of adoption of patient controlled injectors in emerging countries during the forecast period.
Key Market Segments
In terms of products, the electronic injector segment accounted for the largest share of the Asia Pacific patient controlled injectors market in 2019. In terms of application, the cancer treatment segment accounted for the largest share of the Asia Pacific patient controlled injectors market in 2019. In terms of distribution channel, the hospital pharmacies segment accounted for the largest share of the Asia Pacific patient controlled injectors market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacific patient controlled injectors market report are the World Health Organization (WHO), Global Burden of Disease (GBD), The Indian Council for Medical Research, Institute for Health Metrics and Evaluation, International Diabetes Federation (IDF), Australian Bureau of Statistics, Health Ministry of Japan and others.
Reasons to buy report
- It provides understanding of the Asia Pacific, patient controlled injectors market landscape and identifies patient controlled injectors market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific patient controlled injectors market.
- It helps efficiently plan merger and acquisition, and partnership deals in the patient controlled injectors market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of patient controlled injectors market performance of various segments pertaining to the Asia Pacific patient controlled injectors market.
- It provides patient controlled injectors market revenue forecast of the market based on various segments for the period from 2019 to 2027.
ASIA PACIFIC PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION
By Products
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Mail Order Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Johnson and Johnson Services, Inc.
- Sensile Medical AG (Gerresheimer AG)
- F. HOFFMANN-LA ROCHE LTD
- Ypsomed AG
- Westbourne Medical Limited
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Patient Controlled Injectors Market – By Product
1.3.2 Asia Pacific Patient Controlled Injectors Market – By Application
1.3.3 Asia Pacific Patient Controlled Injectors Market – By Distribution Channel
1.3.4 Asia Pacific Patient Controlled Injectors Market – By Country
2. Asia Pacific Patient Controlled Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Patient Controlled Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Patient Controlled Injectors Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Patient Controlled Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market – Asia Pacific Analysis
6.1 Asia Pacific Patient Controlled Injectors Market Revenue Forecasts and Analysis
7. Asia Pacific Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Asia Pacific Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
7.2.1 Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Electronic Injector
7.3.1 Overview
7.3.2 Asia Pacific Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 Asia Pacific Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 Asia Pacific Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Patient Controlled Injectors Market Analysis – By Application
8.1 Overview
8.2 Asia Pacific Patient Controlled Injectors Market, By Application 2019-2027 (%)
8.2.1 Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 Asia Pacific Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 Asia Pacific Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 Asia Pacific Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Patient Controlled Injectors Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asia Pacific Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)
9.2.1 Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 Asia Pacific Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Asia Pacific Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 Asia Pacific Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.5 Asia Pacific Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 China: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 China: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 China Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 China Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.7.4 China Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Japan: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Japan: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Japan Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Japan Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.8.4 Japan Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 India: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 India: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 India Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 India Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.9.4 India Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.10 South Korea: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 South Korea: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 South Korea Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 South Korea Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.10.4 South Korea Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.11 Australia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Australia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Australia Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Australia Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.11.4 Australia Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.12 Rest of Asia Pacific: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.12.1 Rest of Asia Pacific: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.12.2 Rest of Asia Pacific Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.12.3 Rest of Asia Pacific Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.12.4 Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Patient Controlled Injectors Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Sensile Medical AG (Gerresheimer AG)
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ypsomed AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Westbourne Medical Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Asia Pacific Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. Asia Pacific Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 6. Asia Pacific Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. China Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. China Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 9. China Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Japan Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 12. Japan Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. India Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. India Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 15. India Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 18. South Korea Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. Australia Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 21. Australia Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Asia Pacific Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. Rest of Asia Pacific Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Glossary of Terms, Patient Controlled Injectors Market
LIST OF FIGURES
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. Asia Pacific Patient Controlled Injectors Market Overview
Figure 3. Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)
Figure 6. Patient Controlled Injectors Market - Asia Pacific PEST Analysis
Figure 7. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
Figure 10. Asia Pacific Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Patient Controlled Injectors Market, by Application 2019 & 2027 (%)
Figure 14. Asia Pacific Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)
Figure 19. Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Asia Pacific Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 24. Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 25. China: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Japan: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. India: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. South Korea: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Australia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Rest of Asia Pacific: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in Asia Pacifican Country Markets
- Johnson and Johnson Services, Inc.
- Sensile Medical AG (Gerresheimer AG)
- F. HOFFMANN-LA ROCHE LTD
- Ypsomed AG
- Westbourne Medical Limited
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific patient controlled injectors market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.